Publications by authors named "Agusti Barnadas"

Claim this Profile
F
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Federico Rojo, Clive R Taylor, Carlos Barrios, Laura Torrecillas, Manuel Ruiz-Borrego, Agusti Barnadas

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of an Exercise and Educational-Based Prehabilitation Program in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy (PREOptimize) on Functional Outcomes: A Randomized Controlled Trial.
Anabel Casanovas-Álvarez, Blanca Estanyol, Magda Ciendones, Josep Padròs, Jordi Cuartero, Agustí Barnadas

Phys Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients.
Daniel Escuin, Olga Bell, Bárbara García-Valdecasas, Montserrat Clos, Itziar Larrañaga, Agustí Barnadas

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, Rubén Osuna-Gómez, Ariadna Tibau, Agustí Barnadas

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secreted Protein Acidic and Rich in Cysteine ( Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients.
Cristina Arqueros, Juliana Salazar, Alberto Gallardo, Marta Andrés, Ariadna Tibau, Agustí Barnadas

Biomedicines· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehabilitation in Patients With Breast Cancer Receiving Neoadjuvant Therapy to Minimize Musculoskeletal Postoperative Complications and Enhance Recovery (PREOPtimize): A Protocol for a Randomized Controlled Trial.
Anabel Casanovas-Álvarez, Raquel Sebio-Garcia, Magda Ciendones, Jordi Cuartero, Blanca Estanyol, Agustí Barnadas

Phys Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients.
Daniel Escuin, Laura López-Vilaró, Olga Bell, Josefina Mora, Bárbara García-Valdecasas, Agustí Barnadas

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis.
Juan Carlos Vazquez, Silvia Antolin, Manuel Ruiz-Borrego, Sonia Servitja, Emilio Alba, Agusti Barnadas

Clin Transl Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review.
Juan C Vázquez, Antonio Piñero, Francisco J de Castro, Ana Lluch, Miguel Martín, Agustí Barnadas

Clin Transl Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview.
Juan C Vázquez, Antonio Piñero, Francisco Javier de Castro, Ana Lluch, Miguel Martín, Agustí Barnadas

Clin Transl Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Ninety-day mortality and clinical outcomes of patients with solid tumours and COVID-19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective study.
Jose Carlos Tapia, Javier Gavira, Assumpció López, Laia Llobera, Ona Pallise, Agusti Barnadas

Int J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy.
Rubén Osuna-Gómez, Cristina Arqueros, Carla Galano, Maria Mulet, Carlos Zamora, Agustí Barnadas

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.
Aida Bujosa, Consolación Moltó, Thomas J Hwang, José Carlos Tapia, Kerstin N Vokinger, Agustí Barnadas

J Natl Compr Canc Netw· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases.
Daniel Escuin, Laura López-Vilaró, Josefina Mora, Olga Bell, Antonio Moral, Agustí Barnadas

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study.
Miguel J Gil-Gil, Meritxell Bellet, Milana Bergamino, Serafín Morales, Agustí Barnadas

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.
Carlos Zamora, Mariona Riudavets, Georgia Anguera, Letícia Alserawan, Ivana Sullivan, Agustí Barnadas

Cancer Immunol Immunother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer.
Daniel Escuin, Laura López-Vilaró, Olga Bell, Josefina Mora, Antonio Moral, Agustí Barnadas

Front Genet· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
Consolación Molto, Thomas J Hwang, Maria Borrell, Marta Andres, Ignasi Gich, Agustí Barnadas

Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents.
Mariona Riudavets, Joaquin Mosquera, Rosario Garcia-Campelo, Jorgina Serra, Georgia Anguera, Agustí Barnadas

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
Ana Lluch, Carlos H Barrios, Laura Torrecillas, Manuel Ruiz-Borrego, Jose Bines, Agustí Barnadas

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients.
Ivana Sullivan, Pau Riera, Marta Andrés, Albert Altés, Margarita Majem, Agustí Barnadas

Angiogenesis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
Miguel Angel Pavón, Irene Arroyo-Solera, Xavier León, Marta Téllez-Gabriel, David Virós, Agustí Barnadas

Head Neck· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.
Rebeca Font, Josep Alfons Espinas, Agustí Barnadas, Angel Izquierdo, Jaume Galceran

Breast Cancer Res Treat· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
Pedro Sánchez-Rovira, Pilar Zamora, Javier Salvador-Bofill, Serafín Morales, Noelia Martínez-Jáñez, Agustí Barnadas

J Drug Assess· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype.
David Páez, María Tobeña, Julen Fernández-Plana, Ana Sebio, Anna C Virgili, Agustí Barnadas

Br J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis